Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Tourette Syndrome Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Tourette Syndrome Drugmarket, defines the market attractiveness level of Tourette Syndrome Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Tourette Syndrome Drug industry, describes the types of Tourette Syndrome Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Tourette Syndrome Drug market and the development prospects and opportunities of Tourette Syndrome Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Tourette Syndrome Drug market in Chapter 13.
By Player:
Reviva Pharmaceuticals Inc
Neurocrine Biosciences Inc
Psyadon Pharmaceuticals Inc
Abide Therapeutics Inc
Therapix Biosciences Ltd
Synchroneuron Inc
Teva Pharmaceutical Industries Ltd
Catalyst Pharmaceuticals Inc
By Type:
AZD-5213
CPP-115
Dutetrabenazine ER
Ecopipam Hydrochloride
Others
By End-User:
Research Center
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Tourette Syndrome Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Tourette Syndrome Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Tourette Syndrome Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Tourette Syndrome Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Tourette Syndrome Drug Market Analysis and Outlook to 2022
-
7.1 Global Tourette Syndrome Drug Consumption (2017-2022)
-
7.2 United States Tourette Syndrome Drug Consumption (2017-2022)
-
7.3 Europe Tourette Syndrome Drug Consumption (2017-2022)
-
7.4 China Tourette Syndrome Drug Consumption (2017-2022)
-
7.5 Japan Tourette Syndrome Drug Consumption (2017-2022)
-
7.6 India Tourette Syndrome Drug Consumption (2017-2022)
-
7.7 South Korea Tourette Syndrome Drug Consumption (2017-2022)
8 Region and Country-wise Tourette Syndrome Drug Market Analysis and Outlook to 2028
-
8.1 Global Tourette Syndrome Drug Consumption Forecast (2022-2028)
-
8.2 United States Tourette Syndrome Drug Consumption Forecast (2022-2028)
-
8.3 Europe Tourette Syndrome Drug Consumption Forecast (2022-2028)
-
8.4 China Tourette Syndrome Drug Consumption Forecast (2022-2028)
-
8.5 Japan Tourette Syndrome Drug Consumption Forecast (2022-2028)
-
8.6 India Tourette Syndrome Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Tourette Syndrome Drug Consumption Forecast (2022-2028)
9 Global Tourette Syndrome Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Tourette Syndrome Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AZD-5213 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CPP-115 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dutetrabenazine ER Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Ecopipam Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Tourette Syndrome Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Research Center Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Tourette Syndrome Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Tourette Syndrome Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AZD-5213 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CPP-115 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dutetrabenazine ER Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Ecopipam Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Tourette Syndrome Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Tourette Syndrome Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Tourette Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Tourette Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Tourette Syndrome Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Tourette Syndrome Drug Market Competitive Analysis
-
14.1 Reviva Pharmaceuticals Inc
-
14.1.1 Reviva Pharmaceuticals Inc Company Details
-
14.1.2 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product and Service
-
14.2 Neurocrine Biosciences Inc
-
14.2.1 Neurocrine Biosciences Inc Company Details
-
14.2.2 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Product and Service
-
14.3 Psyadon Pharmaceuticals Inc
-
14.3.1 Psyadon Pharmaceuticals Inc Company Details
-
14.3.2 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product and Service
-
14.4 Abide Therapeutics Inc
-
14.4.1 Abide Therapeutics Inc Company Details
-
14.4.2 Abide Therapeutics Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Abide Therapeutics Inc Tourette Syndrome Drug Product and Service
-
14.5 Therapix Biosciences Ltd
-
14.5.1 Therapix Biosciences Ltd Company Details
-
14.5.2 Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Therapix Biosciences Ltd Tourette Syndrome Drug Product and Service
-
14.6 Synchroneuron Inc
-
14.6.1 Synchroneuron Inc Company Details
-
14.6.2 Synchroneuron Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Synchroneuron Inc Tourette Syndrome Drug Product and Service
-
14.7 Teva Pharmaceutical Industries Ltd
-
14.7.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.7.2 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product and Service
-
14.8 Catalyst Pharmaceuticals Inc
-
14.8.1 Catalyst Pharmaceuticals Inc Company Details
-
14.8.2 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Tourette Syndrome Drug
-
Figure Tourette Syndrome Drug Picture
-
Table Global Tourette Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tourette Syndrome Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Tourette Syndrome Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Tourette Syndrome Drug Consumption by Country (2017-2022)
-
Figure United States Tourette Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Tourette Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure China Tourette Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Tourette Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure India Tourette Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Tourette Syndrome Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Tourette Syndrome Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Tourette Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Tourette Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Tourette Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Tourette Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Tourette Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Tourette Syndrome Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AZD-5213 Consumption and Growth Rate (2017-2022)
-
Figure Global CPP-115 Consumption and Growth Rate (2017-2022)
-
Figure Global Dutetrabenazine ER Consumption and Growth Rate (2017-2022)
-
Figure Global Ecopipam Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AZD-5213 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CPP-115 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dutetrabenazine ER Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ecopipam Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Tourette Syndrome Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Tourette Syndrome Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Reviva Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product and Service
-
Table Neurocrine Biosciences Inc (Foundation Year, Company Profile and etc.)
-
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Product and Service
-
Table Psyadon Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product and Service
-
Table Abide Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Abide Therapeutics Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abide Therapeutics Inc Tourette Syndrome Drug Product and Service
-
Table Therapix Biosciences Ltd (Foundation Year, Company Profile and etc.)
-
Table Therapix Biosciences Ltd Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Therapix Biosciences Ltd Tourette Syndrome Drug Product and Service
-
Table Synchroneuron Inc (Foundation Year, Company Profile and etc.)
-
Table Synchroneuron Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synchroneuron Inc Tourette Syndrome Drug Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product and Service
-
Table Catalyst Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product and Service
-
